CB

THC Farmaceuticals IncOOTC CBDG Stock Report

Last reporting period 30 Sep, 2020

Updated 11 Nov, 2024

Last price

Market cap $B

0.003

Micro

Exchange

OOTC - OTC

CBDG Stock Analysis

CB

Uncovered

THC Farmaceuticals Inc is uncovered by Eyestock quantitative analysis.

Market cap $B

0.003

Dividend yield

Shares outstanding

18.132 B

Website

THC Farmaceuticals, Inc. engages in the research and development of cannabis pharmaceutical products. The company is headquartered in Scottsdale, Arizona. The company went IPO on 2012-08-22. The Company, through its subsidiary, CBDual Biotechnology Corp., a pharmaceutical start-up company focuses on developing products based on cannabidiol (CBD) and/or Tetrahydrocannabinol (THC). The firm is engaged cannabis formulations, edibles, and delivery systems of cannabis. The Company’s facility is located in Southern California. The company manufactures and markets cannabis extract products made from cannabis. The company provides access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products. The firm is focused research on the psilocybin for the purpose of conducting clinical trials involving the combination of genetic testing and micro-dosing of psilocybin formulations.

View Section: Eyestock Rating